+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticoagulant"

From
From
Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Ischemic Stroke - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Pulmonary Arterial Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary Arterial Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Deep Vein Thrombosis - Pipeline Insight, 2024 - Product Thumbnail Image

Deep Vein Thrombosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Buerger's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Factor Xa inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Factor Xa inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
P selectin inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

P selectin inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Factor XI inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Factor XI inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Heparin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Heparin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Global Cardiovascular Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Cardiovascular Therapeutics Market 2024-2028

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Global Antithrombotic Drugs Market 2023-2027 - Product Thumbnail Image

Global Antithrombotic Drugs Market 2023-2027

  • Report
  • May 2023
  • 156 Pages
  • Global
From
Coagulation Analyzer Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Coagulation Analyzer Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 145 Pages
  • Global
From
Loading Indicator

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones. The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare. Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more